Ahren_2004_Diabetes.Care_27_2874

Reference

Title : Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes - Ahren_2004_Diabetes.Care_27_2874
Author(s) : Ahren B , Gomis R , Standl E , Mills D , Schweizer A
Ref : Diabetes Care , 27 :2874 , 2004
Abstract : Ahren_2004_Diabetes.Care_27_2874
ESTHER : Ahren_2004_Diabetes.Care_27_2874
PubMedSearch : Ahren_2004_Diabetes.Care_27_2874
PubMedID: 15562200

Related information

Citations formats

Ahren B, Gomis R, Standl E, Mills D, Schweizer A (2004)
Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes
Diabetes Care 27 :2874

Ahren B, Gomis R, Standl E, Mills D, Schweizer A (2004)
Diabetes Care 27 :2874